Spinal Muscular Atrophy Type 2

Rare Disease

Prevalence

1.5 / 100K

Incidence

1.0 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Spinal Muscular Atrophy Type 2?

There are 2 clinical trials targeting Spinal Muscular Atrophy Type 2 tracked by BioSniper.

What is the prevalence of Spinal Muscular Atrophy Type 2?

The estimated prevalence of Spinal Muscular Atrophy Type 2 is approximately 1.5 per 100,000 population.

Deep-dive into Spinal Muscular Atrophy Type 2

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinal Muscular Atrophy Type 2 — Drugs in Development & Clinical Trials | BioSniper